On the afternoon of April 2, Huayi Pharma successfully held the appointment meeting for its new board of directors.

At the meeting, Chairman Gao announced the company's articles of association and elaborated on the responsibilities and obligations of the shareholders' meeting, board of directors, and individual directors. And he announced the new board member list and emphasized: "The addition of new directors brings fresh momentum to the leadership team and will support Huayi Pharma in achieving high-quality, sustainable, and long-term development."

Subsequently, the newly appointed directors - Director Qin, Director Zhou, and Director Cao - delivered their inaugural speeches. They expressed their commitment to fulfilling their duties diligently, upholding the company's idea of "Create value and benefit for the world", leveraging their professional expertise, and working collaboratively with all employees to pioneer a new chapter in Huayi's development.

The successful convening of Huayi's new board member appointment meeting marks the further refinement of the company's decision-making and management, laying a solid foundation for its future development!

In the future, the company will continue to uphold the idea of "Create value and benefit for the world" advancing business development steadily with a professional and pragmatic approach to contribute to the pharmaceutical and healthcare industry.